Literature DB >> 2952576

Phosphofructokinase activity in fibroblasts aneuploid for chromosome 21.

K G Annerén, J R Korenberg, C J Epstein.   

Abstract

Although the gene for the liver type (L) subunit of phosphofructokinase (PFK) is located on human chromosome 21 and PFKL subunits predominate in fibroblasts, an increase in PFK activity has not been reported in trisomy 21 fibroblasts. However, using well-matched pairs of trisomy 21 and diploid fibroblast strains, we observed an almost 1.5-fold increase in mean PFK activity of trisomic cells. In monosomy 21 fibroblasts we found an almost 0.5-fold decrease in mean PFK activity. Thus there appears to be a gene-dosage effect for the PFKL gene, as for other loci on chromosome 21. PFK activity in a cell strain deleted for the distal part of band 21q22.3 was not decreased, suggesting with other data that PFKL is located in the midportion of band 21q22.3.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952576     DOI: 10.1007/bf00283052

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  12 in total

1.  PHOSPHOHEXOKINASE ACTIVITY OF ERYTHROCYTES IN MONGOLISM: ANOTHER POSSIBLE MARKER FOR CHROMOSOME 21.

Authors:  A G BAIKIE; P B LODER; G C DEGRUCHY; D B PITT
Journal:  Lancet       Date:  1965-02-20       Impact factor: 79.321

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  [Enzyme determination of erythrocytes of children with Down syndrome].

Authors:  H Bartels; K Kruse
Journal:  Humangenetik       Date:  1968

4.  Regional mapping of liver type 6 phosphofructokinase isoenzyme on chromosome 21.

Authors:  B Chadefaux; M O Rethoré; D Allard
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

5.  Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.

Authors:  S Vora; C Seaman; S Durham; S Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

6.  Assignment of the gene for F-type phosphofructokinase to human chromosome 10 by somatic cell hybridization and specific immunoprecipitation.

Authors:  D Weil; D Cottreau; R Rebourcet; C Foubert; M S Gross; J C Dreyfus; A Kahn
Journal:  Ann Hum Genet       Date:  1980-07       Impact factor: 1.670

7.  The A2B2 hybrid isozyme of phosphofructokinase.

Authors:  F Gonzalez; R G Kemp
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

8.  Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation- and progression-linked discriminants of malignancy.

Authors:  S Vora; J P Halper; D M Knowles
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

9.  Assignment of the human gene for muscle-type phosphofructokinase (PFKM) to chromosome 1 (region cen leads to q32) using somatic cell hybrids and monoclonal anti-M antibody.

Authors:  S Vora; S Durham; B de Martinville; D L George; U Francke
Journal:  Somatic Cell Genet       Date:  1982-01

10.  Assignment of the human gene for liver-type 6-phosphofructokinase isozyme (PFKL) to chromosome 21 by using somatic cell hybrids and monoclonal anti-L antibody.

Authors:  S Vora; U Francke
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more
  4 in total

1.  Effects of overexpression of the liver subunit of 6-phosphofructo-1-kinase on the metabolism of a cultured mammalian cell line.

Authors:  A M Urbano; H Gillham; Y Groner; K M Brindle
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

2.  Analysis of gene-dosage effects on the expression of CD18 by trisomy 21 lymphoblastoid cell-lines using a statistical model to fit flow cytometry profiles.

Authors:  W G Bardsley; B P McMurray; A Robson; S D'Souza; G M Taylor
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

3.  Overexpression of liver-type phosphofructokinase (PFKL) in transgenic-PFKL mice: implication for gene dosage in trisomy 21.

Authors:  A Elson; D Levanon; Y Weiss; Y Groner
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

Review 4.  Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome.

Authors:  Laszlo Pecze; Elisa B Randi; Csaba Szabo
Journal:  Mol Med       Date:  2020-11-09       Impact factor: 6.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.